Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Michael, Grever"'
Autor:
Nicole O. Williams, Dionisia Quiroga, Courtney Johnson, Adam Brufsky, Mara Chambers, Saveri Bhattacharya, Maria Patterson, Sagar D. Sardesai, Daniel Stover, Maryam Lustberg, Anne M. Noonan, Mathew Cherian, Darlene M. Bystry, Kasey L. Hill, Min Chen, Mitch A. Phelps, Michael Grever, Julie A. Stephens, Bhuvaneswari Ramaswamy, William E. Carson, Robert Wesolowski
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Heat shock protein 90 (HSP90) is a molecular chaperone required for stabilization of client proteins over-activated in triple-negative breast cancer (TNBC). Over-expression of HSP90 client proteins has been implicated in paclitaxel resist
Externí odkaz:
https://doaj.org/article/c53632218637477c91145bbc4eb4d598
Autor:
Farhad Ravandi, Robert J. Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sasha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E. Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B. Johnston, Jeffrey Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A. Parikh, Jae H. Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A. Rogers, Alan Saven, John F. Seymour, Tamar Tadmor, Martin S. Tallman, Constantine S. Tam, Philip A. Thompson, Xavier Troussard, Clive S. Zent, Thorsten Zenz, Pier Luigi Zinzani, Bernhard Wörmann, Kanti Rai, Michael Grever
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 12, Pp 1-7 (2022)
Abstract A significant body of literature has been generated related to the detection of measurable residual disease (MRD) at the time of achieving complete remission (CR) in patients with hairy cell leukemia (HCL). However, due to the indolent natur
Externí odkaz:
https://doaj.org/article/b522c851a9074f98bd78424982d9e633
Autor:
Sunnia T. Chen, Leylah Azali, Lindsay Rosen, Qiuhong Zhao, Tracy Wiczer, Marilly Palettas, John Gambril, Onaopepo Kola-Kehinde, Patrick Ruz, Sujay Kalathoor, Kerry Rogers, Adam Kittai, Michael Grever, Farrukh Awan, John C. Byrd, Jennifer Woyach, Seema A. Bhat, Daniel Addison
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-11 (2022)
Abstract Background Post-market analyses revealed unanticipated links between first-generation Bruton’s tyrosine kinase inhibitor (BTKi) therapy, ibrutinib, and profound early hypertension. Yet, whether this is seen with novel selective second (nex
Externí odkaz:
https://doaj.org/article/d6745f39b574408fa6a4ea02615773a4
Autor:
Seema A. Bhat, John Gambril, Leylah Azali, Sunnia T. Chen, Lindsay Rosen, Marilly Palettas, Tracy E. Wiczer, Sujay Kalathoor, Qiuhong Zhao, Kerry A. Rogers, Adam Kittai, Michael Grever, Farrukh Awan, Patrick Ruz, John C. Byrd, Jennifer Woyach, Daniel Addison
Publikováno v:
Blood. 140:2142-2145
Acalabrutinib, a next-generation Bruton’s tyrosine kinase inhibitor (BTKi), associates with dramatic efficacy against B-cell malignancies. Recently, unexplained ventricular arrhythmias (VAs) with next-generation BTKi-therapy have been reported. Yet
Autor:
Tracy E. Wiczer, Lauren B. Levine, Jessica Brumbaugh, Jessica Coggins, Qiuhong Zhao, Amy S. Ruppert, Kerry Rogers, Anli McCoy, Luay Mousa, Avirup Guha, Nyla A. Heerema, Kami Maddocks, Beth Christian, Leslie A. Andritsos, Samantha Jaglowski, Steven Devine, Robert Baiocchi, Jennifer Woyach, Jeffrey Jones, Michael Grever, Kristie A. Blum, John C. Byrd, Farrukh T. Awan
Publikováno v:
Blood Advances, Vol 1, Iss 20, Pp 1739-1748 (2017)
Abstract: Atrial fibrillation (AF) has been reported in up to 16% of patients taking ibrutinib. Data regarding the management of AF in this patient population are limited, and stroke prevention poses a challenge because of increased risk of bleeding
Externí odkaz:
https://doaj.org/article/54d5dabd52f24cfa86524782f1940ea1
Autor:
Gregory A. Otterson, William E. Carson, Michael Grever, Bonnie Paul, Melanie Davis, Prashant Trikha, Xiaokui Mo, Elizabeth L. McMichael, Erin M. Bertino
Legends for Supplementary figures S1 and S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e856aab9e00205b1903ef46dd3d352c4
https://doi.org/10.1158/1535-7163.22504051
https://doi.org/10.1158/1535-7163.22504051
Autor:
Gregory A. Otterson, William E. Carson, Michael Grever, Bonnie Paul, Melanie Davis, Prashant Trikha, Xiaokui Mo, Elizabeth L. McMichael, Erin M. Bertino
mAbs can induce antibody-dependent cellular cytotoxicity (ADCC) via the innate immune system's ability to recognize mAb-coated cancer cells and activate immune effector cells. Lenalidomide is an immunomodulatory agent with the capacity to stimulate i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01c65380e23245c3af18f69fb3a86206
https://doi.org/10.1158/1535-7163.c.6537607
https://doi.org/10.1158/1535-7163.c.6537607
Autor:
Matthew R. Avenarius, Ying Huang, Jonathan Hyak, John C. Byrd, Seema A. Bhat, Michael Grever, Adam S. Kittai, Kerry A. Rogers, Dan Jones, Weiqiang Zhao, Nyla A. Heerema, Lynne V. Abruzzo, Jennifer Woyach, Cecelia R. Miller
Publikováno v:
Hematological Oncology.
Autor:
Gregory A. Otterson, William E. Carson, Michael Grever, Bonnie Paul, Melanie Davis, Prashant Trikha, Xiaokui Mo, Elizabeth L. McMichael, Erin M. Bertino
Figure S1. Serum cytokine analysis; Figure S2. Flow cytometric analysis of immune cell types.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19b64a47d4c2388a9bf85ea83ca7d520
https://doi.org/10.1158/1535-7163.22504048
https://doi.org/10.1158/1535-7163.22504048
Autor:
Narendranath Epperla, Qiuhong Zhao, Mirela Anghelina, Jasmine Neal, James S. Blachly, Kerry A. Rogers, Gerard Lozanski, Christopher C. Oakes, Seema A. Bhat, Clive S. Zent, Versha Banerji, Michael Grever, Leslie A. Andritsos
Publikováno v:
American Journal of Hematology. 98